WHWK Whitehawk Therapeutics, Inc. - Common Stock
$5.00
가격 · 8월 25, 2026
기준 재무 정보 8월 6, 2026
52주 범위
$2–$5
87% of range
애널리스트 평점
BUY
14 analysts
목표 주가
$8
+50% upside
P/E (TTM)
-15.2
ROE
-13.4%
순이익률
-288.3%
WHWK 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$5.00
시가총액
$236M
P/E (TTM)
-15.2
EPS (TTM)
$-0.33
매출 (TTM)
$7M
배당 수익률
—
ROE
-13.4%
부채/자본
—
52주 범위
$2 – $5
WHWK 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$7M
2018-12-31
→
2025-12-31
EPS
$-0.33
2021-12-31
→
2025-12-31
잉여현금흐름
$-98M
2018-12-31
→
2025-12-31
마진
-288.3%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
WHWK
동종업계 중앙값
P/E (TTM)
-15.2
1.2
P/S (TTM)
33.0
6.3
P/B
1.7
1.6
Price / FCF (주가 / FCF)
-2.4
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
WHWK
동종업계 중앙값
Operating Margin (영업이익률)
-1601.1%
—
Net Profit Margin (순이익률)
-288.3%
-312.6%
ROA
-18.6%
-56.8%
ROE
-13.4%
-83.3%
ROIC
-83.9%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
WHWK
동종업계 중앙값
Current Ratio (유동비율)
10.3
8.5
Quick Ratio (당좌 비율)
10.0
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
WHWK
동종업계 중앙값
Revenue YoY (매출 YoY)
-72.5%
—
Revenue CAGR 3Y (매출 CAGR 3년)
-22.3%
—
Revenue CAGR 5Y (매출 CAGR 5년)
-12.6%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
WHWK
동종업계 중앙값
WHWK 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
14 명의 애널리스트
- 적극 매수 4 28.6%
- 매수 6 42.9%
- 보유 4 28.6%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
6 명의 애널리스트 · 2026-08-22
중앙값
$7.50
지금
$5.00
저가
$4.00
고가
$10.00
중앙값 목표
$7.50
+50.2%
평균 목표
$7.50
+50.2%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.25%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.20 | $-0.30 | 0.10% |
| 2026년 3월 31일 | $-0.32 | $-0.36 | 0.04% |
| 2025년 12월 31일 | $-0.34 | $-0.16 | -0.18% |
| 2025년 9월 30일 | $-0.26 | $0.07 | -0.33% |
| 2025년 6월 30일 | $-0.76 | $0.50 | -1.3% |
| 2025년 3월 31일 | $-0.37 | $-0.47 | 0.10% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| NBP | — | — | — | — | — | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | — |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| CNXU | — | — | — | — | — | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| HUMA | — | — | — | — | — | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Cost of Revenue | $760.0K | $3M | $3M | $1M | $0 | · | · | · | |
| R&D Expense | $91M | $51M | $49M | $33M | $20M | $15M | $13M | $18M | |
| SG&A Expense | $30M | $37M | $45M | $40M | $19M | $2M | $10M | $13M | |
| Operating Expenses | $122M | $93M | $96M | $78M | $112M | $17M | $24M | $31M | |
| Operating Income | $-114M | $-67M | $-72M | $-63M | $-111M | $-3M | $-24M | $-11M | |
| Interest Expense | · | · | $231.0K | $230.0K | $665.0K | $815.0K | · | · | |
| Interest Income | $6M | $4M | $6M | $2M | $13.0K | $41.0K | · | · | |
| Other Non-op | $94M | $4M | $6M | $2M | $1M | $-927.0K | $1M | $784.6K | |
| Pretax Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $2.0K | $2.0K | · | · | |
| Net Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| EPS (Basic) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| EPS (Diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| Shares (Basic) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| Shares (Diluted) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| EBITDA | $-114M | $-67M | $-72M | $-63M | $-111M | $-6M | $-24M | $-11M |
대차대조표 25
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $29M | $63M | $39M | $149M | $4M | $39M | $63M | |
| Short-term Investments | $108M | $19M | $46M | $134M | $0 | · | · | · | |
| Receivables | $0 | $6M | $5M | $2M | $0 | $14M | · | · | |
| Inventory | $0 | $5M | $6M | $2M | $0 | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $4M | $2M | $81.0K | $311.2K | $754.4K | |
| Other Current Assets | · | · | · | · | · | $2M | $734.8K | $615.7K | |
| Current Assets | $149M | $61M | $125M | $180M | $151M | $19M | $40M | $64M | |
| PP&E (Net) | $3.0K | $7M | $5M | $508.0K | $57.0K | $21.0K | $164.2K | $98.4K | |
| PP&E (Gross) | $377.0K | $7M | $5M | $609.0K | $87.0K | $512.1K | $493.0K | $409.6K | |
| Accum. Depreciation | $374.0K | $463.0K | $270.0K | $101.0K | $30.0K | $390.3K | $328.9K | $311.1K | |
| Intangibles | · | · | · | $0 | $4M | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2M | $2M | $2M | · | · | · | |
| Total Assets | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Accounts Payable | $917.0K | $2M | $6M | $4M | $6M | $2M | $439.8K | $595.7K | |
| Accrued Liabilities | $14M | $15M | $14M | $15M | $9M | $4M | · | · | |
| Current Liabilities | $15M | $17M | $26M | $19M | $15M | $30M | $3M | $5M | |
| Capital Leases | $0 | $565.0K | $833.0K | $1M | $474.0K | · | $67.4K | · | |
| Other Non-current Liabilities | $0 | $202.0K | $0 | · | $0 | $97.0K | · | · | |
| Total Liabilities | $15M | $18M | $27M | $26M | $22M | $31M | $3M | $5M | |
| Common Stock | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $4.1K | $4.1K | |
| Retained Earnings | $-353M | $-333M | $-269M | $-203M | $-143M | $-33M | $-142M | $-119M | |
| AOCI | $120.0K | $16.0K | $27.0K | $-115.0K | $0 | · | · | · | |
| Stockholders' Equity | $136M | $52M | $105M | $158M | $136M | $-12M | $-9M | $59M | |
| Liabilities + Equity | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Shares Outstanding | 47,145,719 | 24,681,000 | 24,554,000 | 24,435,000 | 20,895,000 | 2,542,358 | 40,588,004 | 40,588,004 |
현금 흐름 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $193.0K | $169.0K | $159.0K | $105.0K | $9.0K | · | · | |
| Stock-based Comp | $10M | $11M | $12M | $10M | $2M | $139.0K | $1M | $3M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $87.0K | $95.0K | $0 | · | · | |
| Restructuring | $0 | $3M | $0 | · | · | · | · | · | |
| Other Non-cash | $-87M | $-7M | $-6M | $1M | $85M | · | · | · | |
| Operating Cash Flow | $-97M | $-60M | $-60M | $-50M | $-22M | $-13M | $-24M | $-6M | |
| CapEx | $552.0K | $2M | $4M | $444.0K | $46.0K | $19.0K | $237.0K | $37.9K | |
| Investing Cash Flow | $12M | $25M | $83M | $-133M | $25M | $-19.0K | $-237.0K | $-37.9K | |
| Stock Issued | · | · | · | $0 | $155M | $10M | · | $52M | |
| Net Stock Activity | · | · | · | $0 | $155M | $10M | · | $52M | |
| Dividends Paid | · | · | · | $0 | $4M | · | · | · | |
| Financing Cash Flow | $94M | $130.0K | $326.0K | $73M | $142M | $1M | · | $48M | |
| Net Change in Cash | $9M | $-34M | $24M | $-110M | $145M | $-12M | $-24M | $42M | |
| Free Cash Flow | $-98M | $-61M | $-64M | $-50M | $-22M | $-5M | $-24M | $-6M | |
| Levered FCF | · | · | $-64M | $-50M | $-23M | · | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -42.4% | · | -55.5% | |
| Net Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -28.8% | · | -51.6% | |
| Pretax Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.3% | · | · | · | |
| EBITDA Margin | -1600.0% | -258.9% | -294.7% | -410.9% | -9920.7% | -42.4% | · | -55.5% | |
| ROA | -18.6% | -62.8% | -41.5% | -35.4% | -124.6% | -10.2% | -44.7% | -24.4% | |
| ROE | -13.4% | -105.0% | -58.9% | -37.0% | -76.6% | -38.2% | -59.5% | -16.6% | |
| ROIC | -83.9% | -128.6% | -68.4% | -39.6% | -81.5% | · | · | · |
유동성 및 지급능력 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 | 24.0 | 11.9 | 11.7 | |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 | 22.8 | 11.6 | 11.5 | |
| Interest Coverage | · | · | -311.4 | -272.5 | -167.2 | · | · | · |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.3 | 0.2 | 0.1 | 0.0 | 0.4 | · | 0.5 | |
| Inventory Turnover | 0.3 | 0.5 | 0.7 | 1.4 | · | · | · | · | |
| Receivables Turnover | 2.4 | 4.6 | 6.6 | 16.3 | · | · | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -72.5% | 6.7% | 60.1% | 8.7% | 0.00% | · | · | · | |
| Revenue CAGR 3Y | -22.3% | 22.9% | 20.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -12.6% | · | · | · | · | · | · | · |
가치 평가 (TTM) 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Net Income TTM | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| Market Cap | $114M | $78M | $50M | $314M | $505M | $695M | $380M | $1.03B | |
| P/E | -7.3 | -1.3 | -0.8 | -4.8 | -1.9 | · | · | · | |
| P/S | 16.0 | 3.0 | 2.0 | 20.6 | 36.0 | 49.6 | · | 51.3 | |
| P/B | 0.8 | 1.5 | 0.5 | 2.0 | 3.7 | 16.1 | 10.4 | 17.6 | |
| P / Tangible Book | 0.8 | 1.5 | 0.5 | 2.0 | 3.8 | · | · | · | |
| P / Cash Flow | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -129.0 | -15.9 | -178.2 | |
| P / FCF | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -128.5 | -15.8 | -177.0 | |
| Dividend Yield | · | · | · | 0.00% | 0.87% | · | · | · | |
| Earnings Yield | -13.6% | -74.8% | -120.8% | -21.0% | -51.4% | · | · | · | |
| Payout Ratio | · | · | · | 0.00% | -4.0% | · | · | · | |
| Annual Payout | · | · | · | $0 | $4M | · | · | · |
손익계산서 17
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $6M | $5M | $6M | $6M | $6M | $6M | $5M | $4M | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $760.0K | $790.0K | $804.0K | $778.0K | $652.0K | $927.0K | $697.0K | $656.0K | $529.0K | $222.0K | $593.0K | |
| R&D Expense | $13M | $17M | $19M | $14M | $49M | $9M | $14M | $10M | $13M | $14M | $13M | $12M | $13M | $11M | $9M | $9M | |
| SG&A Expense | $5M | $6M | $6M | $5M | $6M | $13M | $11M | $7M | $8M | $11M | $10M | $11M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $18M | $24M | $25M | $20M | $55M | $22M | $26M | $21M | $22M | $25M | $24M | $24M | $26M | $23M | $21M | $19M | |
| Operating Income | $-18M | $-24M | $-25M | $-20M | $-55M | $-15M | $-19M | $-13M | $-16M | $-20M | $-18M | $-18M | $-20M | $-17M | $-15M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $58.0K | · | $58.0K | $58.0K | $58.0K | $56.0K | $58.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $791.0K | $676.0K | $906.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $620.0K | |
| Other Non-op | $1M | $1M | $2M | $2M | $2M | $88M | $676.0K | $867.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $562.0K | |
| Pretax Income | $-17M | $-22M | · | · | $-53M | $73M | · | · | · | · | $-16M | $-16M | $-18M | · | $-14M | $-14M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Net Income | $-17M | $-22M | $-23M | $-18M | $-53M | $73M | $-18M | $-13M | $-15M | $-18M | $-16M | $-16M | $-18M | $-15M | $-14M | $-14M | |
| EPS (Basic) | $-0.20 | $-0.32 | $-1.15 | $-0.26 | $-0.76 | $1.84 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| EPS (Diluted) | $-0.20 | $-0.32 | $-1.14 | $-0.26 | $-0.76 | $1.83 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| Shares (Basic) | 82,886,196 | 69,236,945 | -116,042,087 | 69,204,899 | 69,083,127 | 39,640,826 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| Shares (Diluted) | 82,886,196 | 69,236,945 | -116,333,800 | 69,204,899 | 69,083,127 | 39,932,539 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| EBITDA | $-18M | $-24M | · | $-20M | $-55M | $-15M | · | $-13M | $-16M | $-19M | · | $-18M | $-20M | $-17M | · | $-15M |
대차대조표 24
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $35M | $38M | $38M | $145M | $228M | $29M | $31M | $41M | $54M | $63M | $69M | $68M | $34M | $39M | $135M | |
| Short-term Investments | $105M | $88M | $108M | $125M | $32M | $3M | $19M | $32M | $37M | $34M | $46M | $51M | $67M | $117M | $134M | $48M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $6M | $5M | $5M | $6M | $4M | $6M | $2M | $2M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $2M | $734.0K | |
| Prepaid Expense | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Current Assets | $192M | $126M | $149M | $165M | $179M | $233M | $61M | $77M | $93M | $103M | $125M | $133M | $145M | $165M | $180M | $190M | |
| PP&E (Net) | $1.0K | $2.0K | $3.0K | $4.0K | $9.0K | $25.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $508.0K | $457.0K | |
| PP&E (Gross) | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $609.0K | · | |
| Accum. Depreciation | $376.0K | $375.0K | $374.0K | $373.0K | $368.0K | $352.0K | $463.0K | $416.0K | $369.0K | $320.0K | $270.0K | $226.0K | $183.0K | $140.0K | $101.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Accounts Payable | $1M | $2M | $917.0K | $2M | $3M | $4M | $2M | $1M | $2M | $3M | $6M | $3M | $3M | $7M | $4M | $4M | |
| Accrued Liabilities | $10M | $9M | $14M | $8M | $5M | $9M | $15M | $14M | $14M | $11M | $14M | $12M | $10M | $11M | $15M | $14M | |
| Current Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $17M | $16M | $22M | $20M | $26M | $21M | $13M | $18M | $19M | $18M | |
| Capital Leases | · | · | $0 | $0 | $0 | $0 | $565.0K | $624.0K | $682.0K | $738.0K | $833.0K | $946.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $202.0K | $393.0K | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $18M | $17M | $23M | $21M | $27M | $21M | $20M | $25M | $26M | $25M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-392M | $-375M | $-353M | $-330M | $-312M | $-260M | $-333M | $-314M | $-302M | $-287M | $-269M | $-253M | $-236M | $-218M | $-203M | $-189M | |
| AOCI | $-63.0K | $-15.0K | $120.0K | $139.0K | $9.0K | $1.0K | $16.0K | $39.0K | $-27.0K | $-8.0K | $27.0K | $-16.0K | $-44.0K | $-32.0K | $-115.0K | $-99.0K | |
| Stockholders' Equity | $183M | $116M | $136M | $157M | $172M | $222M | $52M | $69M | $79M | $90M | $105M | $118M | $131M | $146M | $158M | $169M | |
| Liabilities + Equity | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Shares Outstanding | 57,009,010 | 47,196,564 | 47,145,719 | 47,128,362 | 47,128,362 | 46,784,618 | 24,680,708 | 24,614,834 | 24,614,834 | 24,554,205 | 24,554,205 | 24,525,860 | 24,519,860 | 24,436,990 | 24,435,007 | 24,395,117 |
현금 흐름 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $50.0K | $44.0K | $44.0K | $43.0K | $38.0K | $46.0K | $12.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-32.0K | $0 | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $-17M | $-15M | $-53M | $-12M | $-15M | $-16M | $-9M | $-20M | $-10M | $-12M | $-17M | $-21M | $-11M | $-8M | |
| CapEx | $0 | $0 | $0 | $0 | $1.0K | $551.0K | $186.0K | $188.0K | $541.0K | $739.0K | $816.0K | $1M | $689.0K | $1M | $78.0K | $102.0K | |
| Investing Cash Flow | $-17M | $19M | $17M | $-92M | $-29M | $115M | $13M | $5M | $-4M | $11M | $4M | $13M | $51M | $16M | $-84M | $-48M | |
| Financing Cash Flow | $82M | $0 | $25.0K | $0 | $-850.0K | $95M | $53.0K | $0 | $87.0K | $-10.0K | $80.0K | $-75.0K | $313.0K | $8.0K | $-107.0K | $73M | |
| Net Change in Cash | $50M | $-3M | $-363.0K | $-107M | $-83M | $199M | $-2M | $-11M | $-13M | $-9M | $-6M | $641.0K | $34M | $-5M | $-96M | $16M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Free Cash Flow | · | $-22M | · | · | · | $-12M | · | · | · | $-20M | · | · | · | $-23M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -364.5% | · | -299.5% | -315.1% | -286.8% | · | -354.2% | |
| Net Margin | · | · | · | · | · | 1021.9% | · | -174.0% | -236.0% | -341.7% | · | -273.6% | -289.8% | -259.5% | · | -341.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -273.6% | -289.8% | · | · | -341.0% | |
| EBITDA Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -363.6% | · | -299.5% | -315.1% | -286.1% | · | -354.2% | |
| ROA | -8.9% | -12.3% | · | -14.0% | -37.3% | 42.3% | · | -11.1% | -11.5% | -13.0% | · | -9.8% | -12.8% | -9.7% | · | -8.0% | |
| ROE | -9.4% | -13.1% | · | -15.7% | -41.9% | 46.8% | · | -13.4% | -13.9% | -15.5% | · | -11.3% | -15.0% | -11.2% | · | -9.0% | |
| ROIC | -9.9% | -20.2% | · | · | · | · | · | · | · | · | · | -15.1% | -14.9% | · | · | -8.9% |
유동성 및 지급능력 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.4 | 11.4 | · | 16.8 | 20.4 | 19.0 | · | 4.9 | 4.2 | 5.2 | · | 6.5 | 11.2 | 9.3 | · | 10.6 | |
| Quick Ratio | 17.2 | 11.1 | · | 16.5 | 20.2 | 18.8 | · | 4.4 | 3.8 | 4.7 | · | 6.1 | 10.7 | 8.8 | · | 10.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -336.4 | · | -307.7 | -337.0 | -290.1 | · | -259.2 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.3 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.3 | · | 1.6 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 2.9 | · | 1.2 | 1.3 | 1.0 | · | 1.5 | 2.2 | 1.4 | · | 3.7 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $7M | · | $14M | $21M | $26M | · | $25M | $24M | $23M | · | $22M | $20M | $16M | · | $10M | |
| Net Income TTM | $-109M | $-20M | · | $-10M | $-7M | $28M | · | $-62M | $-67M | $-68M | · | $-64M | $-66M | $-62M | · | $-134M | |
| Market Cap | $261M | $163M | · | $90M | $88M | $83M | · | $51M | $36M | $57M | · | $119M | $168M | $177M | · | $345M | |
| P/E | -3.0 | 7.0 | · | 5.4 | 26.7 | 11.9 | · | -0.9 | -0.6 | -0.9 | · | -1.9 | -2.5 | -2.6 | · | -1.2 | |
| P/S | · | 22.8 | · | 6.2 | 4.3 | 3.2 | · | 2.1 | 1.5 | 2.5 | · | 5.3 | 8.5 | 11.2 | · | 34.5 | |
| P/B | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Tangible Book | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -7.3 | · | · | · | -7.0 | · | · | · | -2.9 | · | · | · | -8.3 | · | · | |
| P / FCF | · | -7.3 | · | · | · | -6.7 | · | · | · | -2.8 | · | · | · | -7.8 | · | · | |
| Earnings Yield | -33.6% | 14.2% | · | 18.4% | 3.7% | 8.4% | · | -110.7% | -170.6% | -107.7% | · | -52.1% | -40.8% | -38.4% | · | -80.5% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $7M | $26M | $24M | $15M | $14M |
| 영업이익률 % | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% |
| 순이익 | $-21M | $-64M | $-66M | $-61M | $-110M |
| 희석 EPS | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 |
| 당좌 비율 | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-98M | $-61M | $-64M | $-50M | $-22M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 84개의 제출자 · $187.5M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 29 (+7 이전 분기 대비) | 11 (+7 이전 분기 대비) | 27 (+13 이전 분기 대비) | 13 (+5 이전 분기 대비) | +7.0M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Yu Fan | $22,264,818 | 4,861,314 | 11.87% | 주식 |
| ACUTA CAPITAL PARTNERS, LLC | $21,461,477 | 4,685,912 | 11.44% | 주식 |
| QVT Financial LP | $21,139,947 | 4,615,709 | 11.27% | 주식 |
| MONTANOVA CAPITAL, LLC | $19,694,000 | 4,300,000 | 10.50% | 주식 |
| ORBIMED ADVISORS LLC | $18,019,076 | 3,934,296 | 9.61% | 주식 |
| Avoro Capital Advisors LLC | $13,050,261 | 2,849,402 | 6.96% | 주식 |
| Siren, L.L.C. | $10,703,927 | 2,337,102 | 5.71% | 주식 |
| KVP Capital Advisors, LP | $9,920,266 | 2,165,997 | 5.29% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $6,359,609 | 1,388,561 | 3.39% | 주식 |
| ADAR1 Capital Management, LLC | $6,143,585 | 1,341,394 | 3.28% | 주식 |
| ACORN CAPITAL ADVISORS, LLC | $5,218,283 | 1,139,363 | 2.78% | 주식 |
| STEMPOINT CAPITAL LP | $4,676,349 | 1,021,037 | 2.49% | 주식 |
| Ally Bridge Group (NY) LLC | $3,746,161 | 817,939 | 2.00% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $3,495,462 | 762,997 | 1.86% | 주식 |
| Woodline Partners LP | $1,999,692 | 436,614 | 1.07% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $1,895,305 | 413,822 | 1.01% | 주식 |
| STATE STREET CORP | $1,772,378 | 386,982 | 0.95% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $1,742,259 | 380,406 | 0.93% | 주식 |
| Eversept Partners, LP | $1,389,141 | 303,306 | 0.74% | 주식 |
| Verdad Advisers, LP | $1,380,792 | 301,483 | 0.74% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $1,358,483 | 296,612 | 0.72% | 주식 |
| AMES NATIONAL CORP | $1,333,269 | 4,571 | 0.71% | 주식 |
| Balyasny Asset Management L.P. | $1,319,576 | 288,117 | 0.70% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $1,130,834 | 246,907 | 0.60% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,004,014 | 219,217 | 0.54% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $757,001 | 165,284 | 0.40% | 주식 |
| VANGUARD GROUP INC | $519,881 | 214,827 | 0.28% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $361,051 | 78,832 | 0.19% | 주식 |
| GOLDMAN SACHS GROUP INC | $349,060 | 76,214 | 0.19% | 주식 |
| Point72 Asset Management, L.P. | $261,651 | 57,129 | 0.14% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $237,427 | 51,840 | 0.13% | 주식 |
| Qube Research & Technologies Ltd | $224,388 | 48,993 | 0.12% | 주식 |
| UBS Group AG | $210,098 | 45,873 | 0.11% | 주식 |
| Nuveen, LLC | $200,599 | 43,799 | 0.11% | 주식 |
| Jump Financial, LLC | $186,864 | 40,800 | 0.10% | 주식 |
| DEUTSCHE BANK AG\ | $145,039 | 31,668 | 0.08% | 주식 |
| Bank of New York Mellon Corp | $132,623 | 28,957 | 0.07% | 주식 |
| WELLS FARGO & COMPANY/MN | $124,457 | 27,174 | 0.07% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $123,761 | 27,022 | 0.07% | 주식 |
| RHUMBLINE ADVISERS | $112,338 | 24,529 | 0.06% | 주식 |
| Y-Intercept (Hong Kong) Ltd | $111,583 | 24,363 | 0.06% | 주식 |
| TWO SIGMA ADVISERS, LP | $102,608 | 42,400 | 0.05% | 주식 |
| Vanguard Global Advisers, LLC | $89,205 | 19,477 | 0.05% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $85,646 | 18,700 | 0.05% | 주식 |
| BANK OF AMERICA CORP /DE/ | $85,518 | 18,672 | 0.05% | 주식 |
| XTX Topco Ltd | $84,831 | 18,522 | 0.05% | 주식 |
| CITADEL ADVISORS LLC | $79,440 | 17,345 | 0.04% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $68,434 | 14,942 | 0.04% | 주식 |
| ABG Innovation Capital Partners III GP Ltd | $64,532 | 26,666 | 0.03% | 주식 |
| CITIGROUP INC | $60,209 | 13,146 | 0.03% | 주식 |
| JPMORGAN CHASE & CO | $59,323 | 13,452 | 0.03% | 주식 |
| Invesco Ltd. | $59,261 | 12,939 | 0.03% | 주식 |
| EVERGREEN CAPITAL MANAGEMENT LLC | $50,380 | 11,000 | 0.03% | 주식 |
| Scientech Research LLC | $49,638 | 10,838 | 0.03% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $46,739 | 10,205 | 0.02% | 주식 |
| Quadrature Capital Ltd | $46,002 | 10,044 | 0.02% | 주식 |
| TWO SIGMA SECURITIES, LLC | $45,951 | 10,033 | 0.02% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $31,804 | 6,944 | 0.02% | 주식 |
| NORTHERN TRUST CORP | $23,239 | 5,074 | 0.01% | 주식 |
| BARCLAYS PLC | $22,182 | 4,843 | 0.01% | 주식 |
| US BANCORP \DE\ | $15,265 | 3,333 | 0.01% | 주식 |
| Legal & General Group Plc | $14,482 | 3,162 | 0.01% | 주식 |
| Ameritas Investment Partners, Inc. | $13,488 | 2,945 | 0.01% | 주식 |
| Russell Investments Group, Ltd. | $11,880 | 2,594 | 0.01% | 주식 |
| Tower Research Capital LLC (TRC) | $11,702 | 2,555 | 0.01% | 주식 |
| BlackRock, Inc. | $11,601 | 2,533 | 0.01% | 주식 |
| OSAIC HOLDINGS, INC. | $7,048 | 1,539 | 0.00% | 주식 |
| BARTLETT & CO. WEALTH MANAGEMENT LLC | $6,105 | 1,333 | 0.00% | 주식 |
| ROYAL BANK OF CANADA | $5,000 | 1,114 | 0.00% | 주식 |
| MORGAN STANLEY | $3,490 | 762 | 0.00% | 주식 |
| Sterling Capital Management LLC | $2,995 | 654 | 0.00% | 주식 |
| SATTER MANAGEMENT CO., L.P. | $2,079 | 659 | 0.00% | 주식 |
| SBI Securities Co., Ltd. | $1,452 | 317 | 0.00% | 주식 |
| Quarry LP | $998 | 218 | 0.00% | 주식 |
| TD Waterhouse Canada Inc. | $993 | 232 | 0.00% | 주식 |
| FMR LLC | $779 | 170 | 0.00% | 주식 |
| ACADIAN ASSET MANAGEMENT LLC | $778 | 170,883 | 0.00% | 주식 |
| Caitong International Asset Management Co., Ltd | $664 | 145 | 0.00% | 주식 |
| Integrated Wealth Concepts LLC | $604 | 132 | 0.00% | 주식 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $122 | 26,609 | 0.00% | 주식 |
| CWM, LLC | $86 | 25 | 0.00% | 주식 |
| SIMPLEX TRADING, LLC | $82 | 18 | 0.00% | 주식 |
| Virtu Financial LLC | $66 | 14,479 | 0.00% | 주식 |
| Parallel Advisors, LLC | $37 | 8 | 0.00% | 주식 |
회사 내부자 26 명의 내부자 · 11 임원 · 16 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| David James Lennon | CHIEF EXECUTIVE OFFICER | 2025년 4월 1일 A | 33,429 | 0 | 0 | $0 |
| Brendan Delaney | President and Chief Executive Officer | 2023년 3월 1일 A | 20,000 | 0 | 0 | $0 |
| Stephen J Hoffman | Chief Executive Officer | 2019년 5월 14일 A | 31,967 | 0 | 0 | $0 |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | 2025년 4월 1일 A | 23,944 | 0 | 0 | $0 |
| Joseph H. Gardner | President | 2020년 3월 16일 A | 453,019 | 0 | 0 | $0 |
| Bryan Ball | Chief Technical Operations Officer and SVP, Manufacturing Operations | 2025년 4월 1일 A | 202,853 | 0 | 0 | $0 |
| David Dornan | Chief Scientific Officer | 2025년 3월 4일 A | — | 0 | 0 | $0 |
| Lorettta M Itri | CHIEF MEDICAL OFFICER | 2024년 3월 1일 A | — | 0 | 0 | $0 |
| Kevin G. Peters | Chief Scientific Officer and Acting Chief Medical Officer Exhibit 24: Power of Attorney | 2020년 3월 16일 A | 320,536 | 0 | 0 | $0 |
| Michael W Rogers | Chief Financial and Chief Business Officer | 2019년 5월 14일 A | — | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | 2019년 2월 15일 A | — | 0 | 0 | $0 |
| Baiteng Zhao | 이사 | 2026년 6월 12일 A | 1,250,000 | 0 | 0 | $0 |
| Neil Desai | 이사 | 2026년 6월 12일 A | 1,211,543 | 0 | 0 | $0 |
| Emma Reeve | 이사 | 2026년 6월 12일 A | — | 0 | 0 | $0 |
| Mohammad Hirmand | 이사 | 2026년 6월 12일 A | — | 0 | 0 | $0 |
| Anupam Dalal | 이사 | 2026년 6월 12일 A | 4,685,912 | 0 | 0 | $0 |
| Richard E Maroun | 이사 | 2026년 6월 12일 A | — | 0 | 0 | $0 |
| Caley Castelein | 이사 | 2026년 6월 12일 A | 274,796 | 0 | 0 | $0 |
| Karin M. Hehenberger | 이사 | 2024년 6월 12일 A | — | 0 | 0 | $0 |
| Cheryl Cohen | 이사 | 2021년 6월 17일 A | 8,020 | 0 | 0 | $0 |
| Chau Quang Khuong | 이사 | 2019년 6월 18일 A | 5,193,946 | 0 | 0 | $0 |
| Satter Muneer A | 이사 | 2019년 6월 18일 A | 5,621,835 | 0 | 0 | $0 |
| Paul M Weiss | 이사 | 2017년 3월 15일 P | 1,576,167 | 0 | 0 | $0 |
| Dugel Pravin | — | 2021년 6월 30일 A | 12,568 | 0 | 0 | $0 |
| Steven Prelack | — | 2021년 6월 30일 A | 24,485 | 0 | 0 | $0 |
| Regina Marek | — | 2020년 3월 16일 A | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 13 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC, ANUPAM DALAL, Acuta Capital Fund, LP ×3 제출 서류 | 2026년 5월 18일 | 9.00% | 수정본 | 수동적 투자 | SEC |
| Avoro Capital Advisors LLC, Avoro Ventures LLC, Behzad Aghazadeh ×6 제출 서류 | 2026년 5월 14일 | 19.99% | 수정본 | — | SEC |
| Neil Desai ×5 제출 서류 | 2025년 3월 6일 | 4.90% | 수정본 | — | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×5 제출 서류 | 2025년 3월 5일 | 4.98% | 수정본 | 수동적 투자 | SEC |
| Muneer A. Satter (2) ×5 제출 서류 | 2021년 11월 12일 | — | 최초 제출 | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×4 제출 서류 | 2021년 9월 3일 | — | 최초 제출 | — | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 제출 서류 | 2020년 5월 15일 | — | 최초 제출 | — | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 제출 서류 | 2018년 10월 4일 | — | 최초 제출 | — | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | 2017년 3월 27일 | — | 최초 제출 | — | SEC |
| Venture Investors Early Stage Fund IV Limited Partnership (2), VIESF IV GP LLC (2) | 2017년 3월 27일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2008년 4월 4일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2008년 4월 4일 | — | 최초 제출 | — | SEC |
| Argyris Vassiliou | 2008년 4월 4일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 10 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.50% | 23,692 SH | 2026년 8월 21일 | 일간 |
| IWC · iShares Trust | 0.04% | 112,029 SH | 2026년 8월 21일 | 일간 |
| IWN · iShares Trust | 0.01% | 311,306 SH | 2026년 8월 20일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 28,211 SH | 2026년 8월 19일 | 일간 |
| IWM · iShares Trust | 0.00% | 722,832 SH | 2026년 8월 21일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 20,759 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 470,854 SH | 2026년 8월 19일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 887,972 SH | 2026년 8월 19일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 187,597 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,409 SH | 2026년 8월 19일 | 일간 |